Answer:
Both cloning and gene therapy are types of biotechnology.
Cloning is a type of biotechnology and gene therapy is not a type of biotechnology.
0%?... i mean if 100 million years is half of its life then 300 million years surpasses its entire lifetime which would be 200 million years. Based off of this I don’t believe there’d be anything left
States enjoyed greater autonomy under the Articles, whereas the Constitution granted some powers to the states.
<h3>What is articles of confederation?</h3>
- The 13 founding states of the United States of America came to an agreement known as the Articles of Confederation and Perpetual Union, which functioned as the country's first system of governance.
- On November 15, 1777, the Second Continental Congress approved it following lengthy discussion and forwarded it to the states for ratification.
- In the Articles of Confederation, which served as the nation's first constitution, the confederacy of the former 13 colonies was referred to as "The United States of America."
- The 13 articles that made up the Articles of Confederation granted authority to a federal government headed by Congress.
- Following the United States' declaration of independence from Great Britain, the national government's functions were codified in the Articles of Confederation.
- The Continental Congress approved the Articles of Confederation on November 15, 1777.
- This text functioned as the first constitution of the United States.
- It lasted from March 1, 1781, until the current Constitution took effect in 1789.
Learn more about the articles of confederation here:
brainly.com/question/793228
#SPJ4
Answer:
A. Pharmacogenomics
Explanation:
The use of persons genetic makeup or information or genome, to select or choose the medicine and dosage of the drugs to be administered that will likely work t for that particular person is called Pharmacogenomics . This field of science combines the knowledge of how drugs work, called pharmacology, with the knowledge of the human genome, called genomics.
The aim of Pharmacogenomics is to optimize drug therapy, with consideration on the patients' genotype. Moreover it targets to ensure maximum efficiency with minimum adverse reactions. By utilizing pharmacogenomics, we have a high hope that drug treatments can veer away from the "one-dose-fits-all" approach to medication.
The deeper down you get, the colder the water is
